Market revenue in 2023 | USD 38.5 million |
Market revenue in 2030 | USD 103.9 million |
Growth rate | 15.2% (CAGR from 2023 to 2030) |
Largest segment | Neurology |
Fastest growing segment | Orthopedic |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dental, Orthopedic, Neurology |
Key market players worldwide | GlaxoSmithKline, Hewlett Packard Enterprise Co, Merck KGaA, AstraZeneca PLC, Aprecia Pharmaceuticals, Extend Biosciences, BioDuro, Affini-T Therapeutics, Osmotica Pharmaceutical, FabRx, Cycle Pharmaceuticals |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to 3d printed drugs market will help companies and investors design strategic landscapes.
Neurology was the largest segment with a revenue share of 50.65% in 2023. Horizon Databook has segmented the North America 3d printed drugs market based on dental, orthopedic, neurology covering the revenue growth of each sub-segment from 2018 to 2030.
In 2022, North America dominated the 3D printed drugs market in terms of revenue and market share. Major factors contributing to the growth include the high purchasing power parity, government support for quality healthcare, the availability of suitable reimbursement, and the high prevalence of chronic diseases in the U.S. & Canada.
In addition, the precision medicine initiative is formulating tailored strategies for the unique characteristics of diseases. Hence, such government initiatives are helping improve the overall healthcare system and boosting market growth.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America 3d printed drugs market , including forecasts for subscribers. This continent databook contains high-level insights into North America 3d printed drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account